PTH and hypercalcemia disease: Mutations in <i>CYP24A1</i> can result in elevated 1,25(OH)2D causing parathyroid hormone (PTH)-independent hypercalcemia, hypercalciuria, nephrolithiasis, and nephrocalcinosis.